Listen
Our Platform
Your Library
Sign up
Menu
Login
Sign up →
Close
Listen
Your Library
Prime Network
Our Platform
Login
Sign up →
#cll
Positive Long-Term Data of Ibrutinib + Venetoclax as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL)
Sustained uMRD Demonstrated in Elderly CLL Patients Receiving Ibrutinib plus Venetoclax
Entrevista a Sabrina Corujo, Directora de PPI, en "Somos Nosotros" (1 julio 2020)
Tymon's 1.87 Pyraminx Average and Alg of the Week - TCCP#52
Dr. Bob Martin Sunday, May 21,2017, Hour 1
More
Loading